BigHat Biosciences
CA - San MateoBiotechnology
Focus: BigHat Biosciences applies machine learning and synthetic biology to design safer, more effective biologic therapies. The company is a Series B-stage biotech focused on de novo drug discovery with early-stage pipeline assets.
Profile data last refreshed 8h ago · AI intelligence enriched 2w ago
Funding Stage
SERIES B
Open Jobs
9
Should You Work at BigHat Biosciences?
AI assessmentBest suited for scientists and engineers energized by platform risk and AI/synthetic biology innovation; high technical ceiling but elevated execution risk.
Why Work Here
- Early-stage platform company with AI/ML infrastructure at core, offering exposure to cutting-edge synthetic biology and computational drug design
- Lab Science dominates hiring (6 of 10 open roles), indicating active bench-research expansion and hands-on discovery work
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
BHB810
Gastric CancerClinical Trials (1)
NCT07529808Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
Phase 1/2Help build intelligence for BigHat Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.